Dorsal Root Ganglion Infiltration by Macrophages Contributes to Paclitaxel Chemotherapy-Induced Peripheral Neuropathy

J Pain. 2016 Jul;17(7):775-86. doi: 10.1016/j.jpain.2016.02.011. Epub 2016 Mar 12.

Abstract

Chemotherapy-induced peripheral neuropathy (CIPN) is a disruptive and persistent side effect of cancer treatment with paclitaxel. Recent reports showed that paclitaxel treatment results in the activation of Toll-like receptor 4 (TLR4) signaling and increased expression of monocyte chemoattractant protein 1 (MCP-1) in dorsal root ganglion cells. In this study, we sought to determine whether an important consequence of this signaling and also a key step in the CIPN phenotype was the recruitment and infiltration of macrophages into dorsal root ganglia (DRG). Here, we show that macrophage infiltration does occur in a time course that matches the onset of the behavioral CIPN phenotype in Sprague-Dawley rats. Moreover, depletion of macrophages by systemic administration of liposome-encapsulated clodronate (clophosome) partially reversed behavioral signs of paclitaxel-induced CIPN as well as reduced tumor necrosius factor α expression in DRG. Intrathecal injection of MCP-1 neutralizing antibodies reduced paclitaxel-induced macrophage recruitment into the DRG and also blocked the behavioral signs of CIPN. Intrathecal treatment with the TLR4 antagonist lipopolysaccharide-RS (LPS-RS) blocked mechanical hypersensitivity, reduced MCP-1 expression, and blocked the infiltration of macrophages into the DRG in paclitaxel-treated rats. The inhibition of macrophage infiltration into DRG after paclitaxel treatment with clodronate or LPS-RS prevented the loss of intraepidermal nerve fibers (IENFs) observed after paclitaxel treatment alone. These results are the first to indicate a mechanistic link such that activation of TLR4 by paclitaxel leads to increased expression of MCP-1 by DRG neurons resulting in macrophage infiltration to the DRG that express inflammatory cytokines and the combination of these events results in IENF loss and the development of behavioral signs of CIPN.

Perspective: This paper shows that activation of innate immunity by paclitaxel results in a sequence of signaling events that results in the infiltration of the dorsal root ganglia by activated macrophages. Macrophages appear to drive the development of behavioral hypersensitivity and the loss of distal epidermal nerve fibers, and hence play an important role in the mechanism of paclitaxel-related neuropathy.

Keywords: Cancer; MCP-1; TLR4; TNF-α; neuropathic pain.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics / administration & dosage
  • Animals
  • Antibodies / pharmacology
  • Antigens, CD / metabolism
  • Antigens, Differentiation, Myelomonocytic / metabolism
  • Antineoplastic Agents, Phytogenic / toxicity*
  • Bone Density Conservation Agents / administration & dosage
  • Cell Movement / drug effects*
  • Chemokine CCL2 / immunology
  • Chemokine CCL2 / metabolism
  • Clodronic Acid / administration & dosage
  • Disease Models, Animal
  • Drug Administration Routes
  • GAP-43 Protein / metabolism
  • Ganglia, Spinal / pathology*
  • Hyperalgesia / etiology
  • Isoflurane / administration & dosage
  • Lipopolysaccharides / pharmacology
  • Macrophages / drug effects*
  • Macrophages / physiology
  • Male
  • Paclitaxel / toxicity*
  • Pain Threshold / drug effects
  • Peripheral Nervous System Diseases / chemically induced*
  • Peripheral Nervous System Diseases / drug therapy
  • Peripheral Nervous System Diseases / pathology
  • Rats
  • Rats, Sprague-Dawley
  • Spinal Cord / pathology
  • Spleen / drug effects
  • Spleen / pathology
  • Time Factors
  • Tumor Necrosis Factor-alpha / metabolism
  • Ubiquitin Thiolesterase / metabolism

Substances

  • Anesthetics
  • Antibodies
  • Antigens, CD
  • Antigens, Differentiation, Myelomonocytic
  • Antineoplastic Agents, Phytogenic
  • Bone Density Conservation Agents
  • CD68 antigen, human
  • Ccl2 protein, rat
  • Chemokine CCL2
  • GAP-43 Protein
  • Lipopolysaccharides
  • Tumor Necrosis Factor-alpha
  • Clodronic Acid
  • Isoflurane
  • UCHL1 protein, rat
  • Ubiquitin Thiolesterase
  • Paclitaxel